Frederik Kier

Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark.

Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland.

Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom.

Part of Novo Nordisk A/S, Novo Nordisk Pharma Operations A/S is a Danish company that engages in the pharmaceutical and medicine manufacturing industry. The company is based in Bagsværd, Denmark. The company was founded in 2009. Lars Bo Smidt has been the CEO of the company since 2020.

Novo Nordisk North America Operations A/S is an investment holding Danish company. The company is based in Bagsværd, Denmark. The company was founded in 2011. The CEO is Peter Bøggild.